Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
About this item
Full title
Author / Creator
Hassel, Jessica C. , Piperno-Neumann, Sophie , Rutkowski, Piotr , Baurain, Jean-Francois , Schlaak, Max , Butler, Marcus O. , Sullivan, Ryan J. , Dummer, Reinhard , Kirkwood, John M. , Orloff, Marlana , Sacco, Joseph J. , Ochsenreither, Sebastian , Joshua, Anthony M. , Gastaud, Lauris , Curti, Brendan , Piulats, Josep M. , Salama, April K.S. , Shoushtari, Alexander N. , Demidov, Lev , Milhem, Mohammed , Chmielowski, Bartosz , Kim, Kevin B. , Carvajal, Richard D. , Hamid, Omid , Collins, Laura , Ranade, Koustubh , Holland, Chris , Pfeiffer, Constance and Nathan, Paul
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Tebentafusp is a bispecific molecule that recognizes CD3 and gp100. In a trial in patients with uveal melanoma, median survival at 3 years of follow-up was 21.6 months with tebentafusp and 16.9 months with standard therapy.
Alternative Titles
Full title
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Authors, Artists and Contributors
Author / Creator
Piperno-Neumann, Sophie
Rutkowski, Piotr
Baurain, Jean-Francois
Schlaak, Max
Butler, Marcus O.
Sullivan, Ryan J.
Dummer, Reinhard
Kirkwood, John M.
Orloff, Marlana
Sacco, Joseph J.
Ochsenreither, Sebastian
Joshua, Anthony M.
Gastaud, Lauris
Curti, Brendan
Piulats, Josep M.
Salama, April K.S.
Shoushtari, Alexander N.
Demidov, Lev
Milhem, Mohammed
Chmielowski, Bartosz
Kim, Kevin B.
Carvajal, Richard D.
Hamid, Omid
Collins, Laura
Ranade, Koustubh
Holland, Chris
Pfeiffer, Constance
Nathan, Paul
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11188986
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11188986
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2304753
